Rocket Lab's Order Book Tops 100 Launches as Barclays Opens Coverage With an $85 Target

Rocket Lab approaches its 100th Electron launch in November 2026, backed by a 20-mission Synspective deal and fresh Barclays coverage.

Rocket Lab is approaching a milestone that few commercial launch operators ever reach: the 100th flight of its Electron rocket, penciled in for November 2026. Media accreditation for the mission closes on 14 October, though the exact date remains subject to the usual scheduling shifts that come with spaceflight.

The celebration will land in the middle of a broader reassessment of the company's worth on public markets. Shares finished Friday's European session at EUR 60.90, a modest daily decline of 0.3%, and the stock has given back 7.3% over the past seven days even as it holds a 12% gain across the month.

A Record Contract Underpins the Launch Cadence

The commercial groundwork for that flight tempo was laid roughly a week earlier, when Rocket Lab signed a multi-year agreement with Synspective covering 20 dedicated Electron missions — the largest single commercial contract ever booked for the lightweight launcher. StriX-series radar satellites will be lifted from the company's own pads in New Zealand between 2028 and 2031.

Financial terms were not disclosed, but the strategic weight is hard to miss. Synspective's total manifest now stands at 47 missions, and Rocket Lab's overall backlog has climbed past 100 launches. That steady revenue stream from Electron gives the company a financial spine for more ambitious projects, at a time when many rivals are still wrestling with technical setbacks or licensing hurdles.

Wall Street Recalibrates, but Stays Constructive

Analysts are adjusting their models without abandoning their bullish stance. TD Cowen trimmed its price target on Friday to $90 from $120 while keeping a Buy rating — a recalibration that strips out some of the more exuberant valuation fantasy without questioning the longer-term trajectory. Barclays, meanwhile, initiated coverage on Thursday with an Overweight rating and an $85 target, a vote of confidence that market watchers flagged as a possible catalyst for a turn in sentiment.

The gap between the current share price and those targets lays bare just how much speculative upside the market is still pricing in.

Insider Activity Draws a Closer Look

Attention also turned to transactions from the executive suite. Chief Financial Officer Adam Spice exercised stock options on 1 October and subsequently sold 140,157 Rocket Lab shares in several tranches. According to mandatory filings with the US Securities and Exchange Commission, the sales ran automatically through a Rule 10b5-1 trading plan established on 3 June 2026.

Neutron on NASA's Radar

Adding longer-range growth potential is the institutional pipeline. Bloomberg reported that NASA is preparing a sweeping order for rocket launches in support of its planned lunar base, and Rocket Lab's in-development Neutron vehicle has been named among the possible carriers under discussion. The agency has not announced a selection, but the mere mention of the new rocket system signals the league the company could soon be competing in.

Weighing it all up, the case rests on substance. The Synspective record deal secures Electron fleet utilization for years and confirms commercial demand, while the fresh Barclays endorsement and TD Cowen's reaffirmed Buy reflect faith in the long-term strategy. If Rocket Lab executes on its existing manifest and qualifies Neutron for large government programs, the fundamental value should firm further — and despite the inevitable volatility of the space sector, the operational arguments currently carry the day.